A systematic review of the prevalence and covariates of dementia or relative cognitive impairment in the older African-Caribbean population in Britain

International Journal of Geriatric Psychiatry

Volumn 24, Issue 7, 2009, Pages 657-665

  Adelman, Simon ^a   Blanchard, Martin ^a   Livingston, Gill ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

African Caribbean; Cognitive decline; Cognitive impairment; Dementia; Incidence; Prevalence; Risk factors

Indexed keywords

AFRICAN CARIBBEAN; BIRTHPLACE; CAUCASIAN; COGNITIVE DEFECT; DEMENTIA; HEALTH SURVEY; HUMAN; HYPERTENSION; INDIGENOUS PEOPLE; POPULATION RESEARCH; PREDICTION; PREVALENCE; RACE DIFFERENCE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; UNITED KINGDOM;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; CARIBBEAN REGION; COGNITION DISORDERS; DEMENTIA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 67649371336     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.2186     Document Type: Review

References (40)

1. Boneham MA, Williams KE, Copeland JRM, et al. 1997. Elderly people from ethnic minorities in Liverpool: mental illness, unmet need and barriers to service use. Health Soc Care Comm 5(3): 173-180.
2. Boyle MH. 1998. Guidelines for evaluating prevalence studies. Evid-Based Ment Health 1(2): 37-39.
3. Chaturvedi N, McKeigue PM, Marmot MG. 1993. Resting and ambulatory blood pressure differences in Afro-Caribbeans and Europeans. Hypertens 22: 90-96.
4. Copeland JR, Dewey ME, Griffiths-Jones HM. 1986. A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT. Psychol Med 16: 89-99.
5. Demirovic J, Prineas R, Loewenstein D, et al. 2003. Prevalence of dementia in three ethnic groups: the South Florida program on aging and health. Ann Epidemiol 13: 472-478.
6. Diez Roux AV, Chambless L, Merkin SS, et al. 2002. Socioeconomic disadvantage and change in blood pressure associated with ageing. Circulation 2002 106(6): 703-710.
7. Dimsdale JE. 2000. Stalked by the past: the influence of ethnicity on health. Psychosom Med 62: 161-170.
8. Evans DA, Bennett DA, Wilson RS, et al. 2003. Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status. Arch Neurol 60: 185-189.
9. Evans RM, Emsley CL, Gao S, et al. 2000. Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: a population-based study of African Americans. Neurology 54: 240-242.
10. Farrer LA, Cupples LA, Haines JL, et al. 1997. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A. meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278: 1349-1356.
11. Fillenbaum GG, Heyman A, Huber MS, et al. 1998. The prevalence and 3-year incidence of dementia in older Black and White community residents. J Clin Epidemiol 51: 587-595.
12. Folstein MF, Bassett SS, Anthony JC, et al. 1991. Dementia: case ascertainment in a community survey. J Gerontol 46: M132-138.
13. Folstein MF, Folstein SE, McHugh PR. 1975. 'Mini-Mental State'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
14. Gurland B, Golden RR, Teresi JA, Challop J. 1984. The SHORT-CARE: an efficient instrument for the assessment of depression, dementia and disability. J Gerontol 39: 166-169.
15. Hall WD. 1999. A rational approach to the treatment of hypertension in special populations. Am Fam Physician 60: 156-162.
16. Hankey GJ, Eikelboom JW. 1999. Homocysteine and vascular disease. Lancet 354: 407-413.
17. Hendrie HC, Ogunniyi A, Hall KS, et al. 2001. Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. JAMA 285: 739-747.
18. Heyman A, Fillenbaum G, Prosnitz B, et al. 1991. Estimated prevalence of dementia among elderly black and white community residents. Arch Neurol 48: 594-598.
19. Jordanova V, Stewart R, Davies E, et al. 2007. Markers of inflammation and cognitive decline in an African-Caribbean population. Int J Geriatr Psychiatry 22: 966-973.
20. Kim JM, Stewart R, Shin IS, Yoon JS. 2003. Limb length and dementia in an older Korean population. J Neurol Neurosurg Psychiatry 74: 427-432.
21. Krishnan LL, Petersen NJ, Snow AL, et al. 2005. Prevalence of dementia among Veterans Affairs medical care system users. Dement Geriatr Cogn Disord 20: 245-253.
22. Lane D, Beevers DG, Lip GY. 2002. Ethnic differences in blood pressure and the prevalence of hypertension in England. J Hum Hypertens 16: 267-273.
23. Livingston G, Leavey G, Kitchen G, et al. 2001. Mental health of migrant elders - the Islington study. Br J Psychiatry 179: 361-366.
24. Luchsinger JA, Tang MX, Stern Y, et al. 2001. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol 154: 635-641.
25. Mak Z, Kim JM, Stewart R. 2006. Leg length, cognitive impairment and cognitive decline in an African-Caribbean population. Int J Geriatr Psychiatry 21: 266-272.
26. McCracken CF, Boneham MA, Copeland JR, et al. 1997. Prevalence of dementia and depression among elderly people in black and ethnic minorities. Br J Psychiatry 171: 269-273.
27. Murray MD, Lane KA, Gao S, et al. 2002. Preservation of cognitive function with antihypertensive medications: a longitudinal analysis of a community-based sample of African Americans. Arch Intern Med 162: 2090-2096.
28. Nelson T, Fernandez JL, Livingston G, et al. 2004. Does diagnosis determine delivery? The Islington study of older people's needs and health care costs. Psychol Med 34: 147-155.
29. Onwuanyi A, Hodges D, Avancha A, et al. 1998. Hypertensive vascular disease as a cause of death in blacks versus whites: autopsy findings in 587 adults. Hypertension 31: 1070-1076.
30. Richards M, Brayne C, Dening T, et al. 2000. Cognitive function in UK community-dwelling African Caribbean and white elders: a pilot study. Int J Geriatr Psychiatry 15: 621-630.
31. Skoog I, Gustafson D. 2003. Hypertension, hypertension-clustering factors and Alzheimer's disease. Neurol Res 25: 675-680.
32. Stevens T, Leavey G, Livingston G. 2004. Dementia and hypertension in African/Caribbean elders. Age Ageing 33: 193-195.
33. Stewart R. 1998. Cardiovascular factors in Alzheimer's disease. J Neurol Neurosurg Psychiatry 65: 143-147.
34. Stewart R, Asonganyi B, Sherwood R. 2002. Plasma homocysteine and cognitive impairment in an older British African-Caribbean population. J Am Geriatr Soc 50: 1227-1232.
35. Stewart R, Powell J, Prince M, Mann A. 2004. ACE genotype and cognitive decline in an African-Caribbean population. Neurobiol Aging 25: 1369-1375.
36. Stewart R, Prince M, Mann A. 2003. Age, vascular risk, and cognitive decline in an older, British, African-Caribbean population. J Am Geriatr Soc 51: 1547-1553.
37. Stewart R, Richards M, Brayne C, Mann A. 2001a. Vascular risk and cognitive impairment in an older, British, African-Caribbean population. J Am Geriatr Soc 49: 263-269.
38. Stewart R, Russ C, Richards M, et al. 2001b. Apolipoprotein E genotype, vascular risk and early cognitive impairment in an African Caribbean population. Dement Geriatr Cogn Disord 12: 251-256.
39. Tang MX, Cross P, Andrews H, et al. 2001. Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology 56: 49-56.
40. Tang MX, Stern Y, Marder K, et al. 1998. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA 279: 751-755.